A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of FB102 after single and multiple ascending dose administrations in healthy participants
100 项与 Forte Biosciences Australia Pty Ltd. 相关的临床结果
0 项与 Forte Biosciences Australia Pty Ltd. 相关的专利(医药)
100 项与 Forte Biosciences Australia Pty Ltd. 相关的药物交易
100 项与 Forte Biosciences Australia Pty Ltd. 相关的转化医学